EVNIN LUKE sold 14.1% of their position (274.62K shares) of WEREWOLF THERAPEUTICS, INC. on the open market
Open‑market sale worth $198.3K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 3 sales
Filed: 5/4/2026ACC: 0001134657-26-000008
Director10% Owner
Since Apr 2021
-274.62K
Net shares
Net seller
$198.3K
Total sold
3
Open market trades
0B · 3S
3
Total transactions
274.62K disposed
Non-Derivative Transactions3
Common Stock
Indirect
Shares
−168.26K
Price / share
$0.72
Trade value
$121.15K
% of position
8.6%
4/30/2026
1.95M→1.79M
Common Stock
Indirect
Shares
−58.39K
Price / share
$0.73
Trade value
$42.63K
% of position
3.3%
5/1/2026
1.79M→1.73M
Common Stock
Indirect
Shares
−47.96K
Price / share
$0.72
Trade value
$34.53K
% of position
2.8%
5/4/2026
1.73M→1.68M
Total
Net shares
−274.62K
Net value
-$198.31K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 4/30/2026 | S · Sale | −168.26K | $0.72 | $121.15K | 8.6% | 1.95M | 1.79M |
| Common Stock Indirect | 5/1/2026 | S · Sale | −58.39K | $0.73 | $42.63K | 3.3% | 1.79M | 1.73M |
| Common Stock Indirect | 5/4/2026 | S · Sale | −47.96K | $0.72 | $34.53K | 2.8% | 1.73M | 1.68M |
| Total | −274.62K | -$198.31K | ||||||
Derivative Transactions0
No derivative transactions reported